124 related articles for article (PubMed ID: 19763440)
21. Autotaxin and lysophospholipids in rheumatoid arthritis.
Bourgoin SG; Zhao C
Curr Opin Investig Drugs; 2010 May; 11(5):515-26. PubMed ID: 20419597
[TBL] [Abstract][Full Text] [Related]
22. Mammary tumorigenesis through LPA receptor signaling.
Jonkers J; Moolenaar WH
Cancer Cell; 2009 Jun; 15(6):457-9. PubMed ID: 19477423
[TBL] [Abstract][Full Text] [Related]
23. Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer.
Murph M; Tanaka T; Liu S; Mills GB
Clin Cancer Res; 2006 Nov; 12(22):6598-602. PubMed ID: 17121877
[TBL] [Abstract][Full Text] [Related]
24. Lysophosphatidic acid is a lipid mediator with wide range of biological activities. Biosynthetic pathways and mechanism of action.
Berdichevets IN; Tyazhelova TV; Shimshilashvili KhR; Rogaev EI
Biochemistry (Mosc); 2010 Sep; 75(9):1088-97. PubMed ID: 21077828
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of lysophosphatidic acid production.
Aoki J
Semin Cell Dev Biol; 2004 Oct; 15(5):477-89. PubMed ID: 15271293
[TBL] [Abstract][Full Text] [Related]
26. Autotaxin and lipid signaling pathways as anticancer targets.
Braddock DT
Curr Opin Investig Drugs; 2010 Jun; 11(6):629-37. PubMed ID: 20496257
[TBL] [Abstract][Full Text] [Related]
27. Lysophospholipids in the limelight: autotaxin takes center stage.
Moolenaar WH
J Cell Biol; 2002 Jul; 158(2):197-9. PubMed ID: 12135981
[TBL] [Abstract][Full Text] [Related]
28. Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta.
Iwasawa Y; Fujii T; Nagamatsu T; Kawana K; Okudaira S; Miura S; Matsumoto J; Tomio A; Hyodo H; Yamashita T; Oda K; Kozuma S; Aoki J; Yatomi Y; Taketani Y
Am J Reprod Immunol; 2009 Aug; 62(2):90-5. PubMed ID: 19614625
[TBL] [Abstract][Full Text] [Related]
29. [Phosphodiesterases that extracellularly produces a lysolipid mediator].
Tokumura A
Seikagaku; 2006 Dec; 78(12):1141-54. PubMed ID: 17243635
[No Abstract] [Full Text] [Related]
30. Lysophosphatidic acid, a disintegrin and metalloprotease-17 and heparin-binding epidermal growth factor-like growth factor in ovarian cancer: the first word, not the last.
Braun AH; Coffey RJ
Clin Cancer Res; 2005 Jul; 11(13):4639-43. PubMed ID: 16000554
[No Abstract] [Full Text] [Related]
31. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2.
Eder AM; Sasagawa T; Mao M; Aoki J; Mills GB
Clin Cancer Res; 2000 Jun; 6(6):2482-91. PubMed ID: 10873103
[TBL] [Abstract][Full Text] [Related]
32. Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions.
Nakasaki T; Tanaka T; Okudaira S; Hirosawa M; Umemoto E; Otani K; Jin S; Bai Z; Hayasaka H; Fukui Y; Aozasa K; Fujita N; Tsuruo T; Ozono K; Aoki J; Miyasaka M
Am J Pathol; 2008 Nov; 173(5):1566-76. PubMed ID: 18818380
[TBL] [Abstract][Full Text] [Related]
33. Virtual screening approaches for the identification of non-lipid autotaxin inhibitors.
Parrill AL; Echols U; Nguyen T; Pham TC; Hoeglund A; Baker DL
Bioorg Med Chem; 2008 Feb; 16(4):1784-95. PubMed ID: 18036821
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors.
Cui P; Tomsig JL; McCalmont WF; Lee S; Becker CJ; Lynch KR; Macdonald TL
Bioorg Med Chem Lett; 2007 Mar; 17(6):1634-40. PubMed ID: 17257836
[TBL] [Abstract][Full Text] [Related]
35. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells.
Ren J; Xiao YJ; Singh LS; Zhao X; Zhao Z; Feng L; Rose TM; Prestwich GD; Xu Y
Cancer Res; 2006 Mar; 66(6):3006-14. PubMed ID: 16540649
[TBL] [Abstract][Full Text] [Related]
36. Autotaxin stimulates urokinase-type plasminogen activator expression through phosphoinositide 3-kinase-Akt-nuclear [corrected] factor kappa B signaling cascade in human melanoma cells.
Lee J; Duk Jung I; Gyo Park C; Han JW; Young Lee H
Melanoma Res; 2006 Oct; 16(5):445-52. PubMed ID: 17013094
[TBL] [Abstract][Full Text] [Related]
37. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid.
Inoue M; Xie W; Matsushita Y; Chun J; Aoki J; Ueda H
Neuroscience; 2008 Mar; 152(2):296-8. PubMed ID: 18280050
[TBL] [Abstract][Full Text] [Related]
38. Beta-catenin, cancer, and G proteins: not just for frizzleds anymore.
Malbon CC
Sci STKE; 2005 Jul; 2005(292):pe35. PubMed ID: 16014605
[TBL] [Abstract][Full Text] [Related]
39. A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation.
Gierse J; Thorarensen A; Beltey K; Bradshaw-Pierce E; Cortes-Burgos L; Hall T; Johnston A; Murphy M; Nemirovskiy O; Ogawa S; Pegg L; Pelc M; Prinsen M; Schnute M; Wendling J; Wene S; Weinberg R; Wittwer A; Zweifel B; Masferrer J
J Pharmacol Exp Ther; 2010 Jul; 334(1):310-7. PubMed ID: 20392816
[TBL] [Abstract][Full Text] [Related]
40. Biological effects of lysophospholipids.
Rivera R; Chun J
Rev Physiol Biochem Pharmacol; 2008; 160():25-46. PubMed ID: 18481029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
